PREXTON THERAPEUTICS ANNOUNCE


PREXTON THERAPEUTICS ANNOUNCE

January 22, 2013. Prexton Therapeutics will  develop novel mGluR4 PAM series, via an exclusive option on a license agreement with Domain Therapeutics

Download the PDF file